Concepedia

A. Nagel

AN

23

Publications

1.4K

Citations

17

H-Index

1972

Active since

Affiliations

Pfizer (United States)(Current)

Graduate School Experimental Plant Sciences

A. Nagel is an author at Pfizer (United States) specializing in biochemistry, natural sciences, and chemistry.

Top concepts

BiochemistryNatural SciencesChemistryPharmacologyOrganic ChemistryMedicineDrug DiscoveryMedicinal ChemistryDerivativesMicrobiology

Publications per year

1972–2009

23

Publications

23

Macrolide antibiotics. Chemistry, biology, and practice

A. Nagel · Journal of Pharmaceutical Sciences · 1985 · 478 citations

Antimicrobial Drug Discovery, Antibiotics, Medicine +10

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 237 citations · Full text

<sup>13</sup>C‐NMR. Spectroscopy of Naturally Occurring Substances. XXXV. Labdanic diterpenes

Brian L. Buckwalter, Ivor R. Burfitt, A. Nagel et al. · Helvetica Chimica Acta · 1975 · 114 citations

Derivative (Chemistry), Derivatives, Engineering +13

2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity <i>in vitro</i> and <i>in vivo</i>

W. Stephen Faraci, A. Nagel, Kimberly A. Verdries et al. · British Journal of Pharmacology · 1996 · 64 citations · Full text

Molecular Pharmacology, Biochemistry, Potent Inhibitor +10

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents

John Lowe, Thomas Seeger, A. Nagel et al. · Journal of Medicinal Chemistry · 1991 · 53 citations · Full text

Rows per page

1–5 of 23